Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
44%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
44%
ALSO IN FTXH
FTXH
51
HOLDINGS
24%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
| ABBVIE INC | 9.6% | 7.3% | 7.3% | |
| ELI LILLY & CO | 18.8% | 7.3% | 7.3% | |
| JOHNSON & JOHNSON | 6.2% | 7.2% | 6.2% | |
| MERCK & CO. INC. | 4.7% | 7.1% | 4.7% | |
| PFIZER INC | 3.5% | 7.1% | 3.5% | |
MEDX Overweight Relative to FTXH
| ELI LILLY & CO | 11.5% | |
| NOVARTIS AG-ADR | 6.6% | |
| ASTRAZENECA PLC | 4.6% | |
| ALKERMES PLC | 4.0% | |
| CRISPR THERAPEUTICS AG | 2.7% | |
| IONIS PHARMACEUTICALS, INC. | 2.6% | |
| GLAXOSMITHKLINE PLC-SPON ADR | 2.6% | |
| ABBVIE INC | 2.3% | |
| ALNYLAM PHARMACEUTICALS INC | 1.7% | |
| AMGEN INC | 1.2% |
MEDX Underweight Relative to FTXH
| GILEAD SCIENCES INC | -3.7% | |
| PFIZER INC | -3.6% | |
| VIATRIS, INC. | -3.5% | |
| INCYTE CORP | -3.5% | |
| VERTEX PHARMACEUTICALS INC | -3.4% | |
| ZOETIS INC | -3.3% | |
| UNITED THERAPEUTICS CORP | -2.9% | |
| JAZZ PHARMACEUTICALS PLC | -2.7% | |
| MERCK & CO. INC. | -2.4% | |
| EXELIXIS INC | -2.3% |